Foyer of Lecture Hall 4

The optical principles of confocal microscopy were described by Minsky in 1955, who cited his rationale for developing this device

The “ideal endpoint” for trials in Diabetic Peripheral Neuropathy (DPN) has been debated for many years and remains a “rhetorical question”

Skin biopsy is currently considered the gold standard to define the diagnosis of small fibre neuropathy, even though results should be interpreted within the clinical 

The real-world variability in clinical presentation of diabetic distal symmetric polyneuropathy (or “diabetic neuropathy”) and complexities

Corneal confocal microscopy (CCM) has been shown to be an objective, non-invasive diagnostic tool for evaluation of small nerve fiber loss, especially in patients with diabetes mellitus. 

Artificial intelligence (AI) is defined as the capability of a machine to imitate intelligent human behaviour and is being increasingly used in healthcare settings. 

The prevalence of obesity is increasing worldwide which will be followed by an increase in associated complications as well as increased morbidity and mortality

Hyperlipidaemia is associated with the development of neuropathy. Indeed, a mechanistic link between altered lipid metabolism and peripheral nerve dysfunction has been demonstrated in a number of experimental and clinical studies.

 Foyer of Lecture Hall 4

Distal sensory polyneuropathy (DSP) results from damage to the peripheral nerves that presents as a variable cluster of symptoms and signs including pain, tingling, hyperalgesia, allodynia, sensory loss, and gait instability.

Confocal microscopy to visualize corneal nerves has been applied to many non-human species, from cats and dogs to the eagle owl

Clinical trial end-points are critical to the success of drug development of new therapies. Choosing the wrong end-point can result in the apparent failure of a new drug

Immune-mediated neuropathies, such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), are treatable conditions of the peripheral nervous system

Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the nervous system and a common cause of neurological disability in young adults.

It is difficult for individuals at-risk of dementia to undertake routine screening tests. The ADDF diagnostic accelerator program

The hallmark of Parkinson’s disease (PD) is death of dopamine neurons in the brain. Due to lack of validated biomarkers of PD progression, a major challenge is around how to accurately monitor neuronal loss

Neurology as a clinical speciality that managements patients with degenerative disorders (Alzheimer’s disease), peripheral nerve and muscle disorders (neuropathies and myopathies)

This conference came about from discussions among several including one very skeptical person (DRC) about the value of CCM